Among the GLP-1 RAs and a dual GLP-1/GIP RA, exenatide has the most developed pharmacokinetic model (9 of 30), 61,177184 followed by semaglutide (8 of 30), 68,162,182,185189 liraglutide and dulaglutide (each 5 of 30), 156,177,182,189194 and tirzepatide (3 of 30)
Some patients start with weekly injections, then transition to monthly maintenance once levels stabilize
These data were obtained directly from the respective pharmaceutical companies
Lancet 2021;397:97184.ArticlePubMed 48
Heart Protection : It has protective effects on the heart, contributing to cardiovascular health
Sleep apnea (SA) is a sleep disorder marked by recurrent episodes of halted breathing, resulting in frequent arousal and intermittent hypoxia [7], and affecting 425% of adults [8]